Alpha sarcoglycan is required for FGF-dependent myogenic progenitor cell proliferation in vitro and in vivo

Development

Volumn 138, Issue 20, 2011, Pages 4523-4533

  Cassano, Marco ^a   Dellavalle, Arianna ^b   Tedesco, Francesco Saverio ^b   Quattrocelli, Mattia ^a   Crippa, Stefania ^a   Ronzoni, Flavio ^c   Salvade, Agnese ^d   Berardi, Emanuele ^a   Torrente, Yvan ^e   Cossu, Giulio ^b,e   Sampaolesi, Maurilio ^a,c  

^a SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Cell therapy; Limb girdle muscular dystrophy; Mouse; Myogenic progenitor cells

Indexed keywords

ALPHA SARCOGLYCAN; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; DYSTROPHIN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MYOGENIC FACTOR;

ARTICLE; CELL PROLIFERATION; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ANIMALS; BASE SEQUENCE; CELL LINE; CELL PROLIFERATION; DNA PRIMERS; FIBROBLAST GROWTH FACTORS; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, KNOCKOUT; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHY, ANIMAL; MYOBLASTS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SARCOGLYCANOPATHIES; SARCOGLYCANS;

MUS;

EID: 80053089526     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.070706     Document Type: Article

References (55)

1. Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F. et al. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410-2413.
2. Alameddine, H. S., Dehaupas, M. and Fardeau, M. (1989). Regeneration of skeletal muscle fibers from autologous satellite cells multiplied in vitro. An experimental model for testing cultured cell myogenicity. Muscle Nerve 12, 544-555.
3. Allen, R. E. and Boxhorn, L. K. (1989). Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J. Cell. Physiol. 138, 311-315.
4. Allikian, M. J., Hack, A. A., Mewborn, S., Mayer, U. and McNally, E. M. (2004). Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle. J. Cell Sci. 117, 3821-3830.
5. Anastasi, G., Cutroneo, G., Rizzo, G., Arco, A., Santoro, G., Bramanti, P., Vitetta, A. G., Pisani, A., Trimarchi, F. and Favaloro, A. (2004). Sarcoglycan and integrin localization in normal human skeletal muscle: a confocal laser scanning microscope study. Eur. J. Histochem. 48, 245-252.
6. Biressi, S., Tagliafico, E., Lamorte, G., Monteverde, S., Tenedini, E., Roncaglia, E., Ferrari, S., Cusella-De Angelis, M. G., Tajbakhsh, S. and Cossu, G. (2007). Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells. Dev. Biol. 304, 633-651.
7. Blau, H. M., Webster, C. and Pavlath, G. K. (1983). Defective myoblasts identified in Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA 80, 4856-4860.
8. Cassano, M., Quattrocelli, M., Crippa, S., Perini, I., Ronzoni, F. and Sampaolesi, M. (2009). Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass. J. Muscle Res. Cell Motil. 30, 243-253.
9. Collins, C. A., Olsen, I., Zammit, P. S., Heslop, L., Petrie, A., Partridge, T. A. and Morgan, J. E. (2005). Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122, 289-301.
10. Cossu, G. and Biressi, S. (2005). Satellite cells, myoblasts and other occasional myogenic progenitors: possible origin, phenotypic features and role in muscle regeneration. Semin. Cell Dev. Biol. 16, 623-631.
11. Cossu, G. and Sampaolesi, M. (2007). New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol. Med. 13, 520-526.
12. Cossu, G., Zani, B., Coletta, M., Bouche, M., Pacifici, M. and Molinaro, M. (1980). In vitro differentiation of satellite cells isolated from normal and dystrophic mammalian muscles. A comparison with embryonic myogenic cells. Cell Differ. 9, 357-368.
13. Dellavalle, A., Sampaolesi, M., Tonlorenzi, R., Tagliafico, E., Sacchetti, B., Perani, L., Innocenzi, A., Galvez, B. G., Messina, G., Morosetti, R. et al. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 9, 255-267.
14. Derossi, D., Williams, E. J., Green, P. J., Dunican, D. J. and Doherty, P. (1998). Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide. Biochem. Biophys. Res. Commun. 251, 148-152.
15. DiMario, J. and Strohman, R. C. (1988). Satellite cells from dystrophic (mdx) mouse muscle are stimulated by fibroblast growth factor in vitro. Differentiation 39, 42-49.
16. Duclos, F., Straub, V., Moore, S. A., Venzke, D. P., Hrstka, R. F., Crosbie, R. H., Durbeej, M., Lebakken, C. S., Ettinger, A. J., van der Meulen, J. et al. (1998). Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J. Cell Biol. 142, 1461-1471.
17. Filla, M. S., Dam, P. and Rapraeger, A. C. (1998). The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity. J. Cell. Physiol. 174, 310-321.
18. Fukada, S., Morikawa, D., Yamamoto, Y., Yoshida, T., Sumie, N., Yamaguchi, M., Ito, T., Miyagoe-Suzuki, Y., Takeda, S., Tsujikawa, K. et al. (2010). Genetic background affects properties of satellite cells and mdx phenotypes. Am. J. Pathol. 176, 2414-2424.
19. Gal-Levi, R., Leshem, Y., Aoki, S., Nakamura, T. and Halevy, O. (1998). Hepatocyte growth factor plays a dual role in regulating skeletal muscle satellite cell proliferation and differentiation. Biochim. Biophys. Acta 1402, 39-51.
20. Gil-Gomez, G., Berns, A. and Brady, H. J. (1998). A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J. 17, 7209-7218.
21. Gnocchi, V. F., White, R. B., Ono, Y., Ellis, J. A. and Zammit, P. S. (2009). Further characterisation of the molecular signature of quiescent and activated mouse muscle satellite cells. PLoS One 4, e5205.
22. Henry, M. D. and Campbell, K. P. (1996). Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr. Opin. Cell Biol. 8, 625-631.
23. Itoh, N., Mima, T. and Mikawa, T. (1996). Loss of fibroblast growth factor receptors is necessary for terminal differentiation of embryonic limb muscle. Development 122, 291-300.
24. Johnson, S. E. and Allen, R. E. (1995). Activation of skeletal muscle satellite cells and the role of fibroblast growth factor receptors. Exp. Cell Res. 219, 449-453.
25. Kastner, S., Elias, M. C., Rivera, A. J. and Yablonka-Reuveni, Z. (2000). Gene expression patterns of the fibroblast growth factors and their receptors during myogenesis of rat satellite cells. J. Histochem. Cytochem. 48, 1079-1096.
26. Kilkenny, D. M. and Hill, D. J. (1996). Perinuclear localization of an intracellular binding protein related to the fibroblast growth factor (FGF) receptor 1 is temporally associated with the nuclear trafficking of FGF-2 in proliferating epiphyseal growth plate chondrocytes. Endocrinology 137, 5078-5089.
27. Klinge, L., Dekomien, G., Aboumousa, A., Charlton, R., Epplen, J. T., Barresi, R., Bushby, K. and Straub, V. (2008). Sarcoglycanopathies: can muscle immunoanalysis predict the genotype? Neuromuscul. Disord. 18, 934-941.
28. Kobuke, K., Piccolo, F., Garringer, K. W., Moore, S. A., Sweezer, E., Yang, B. and Campbell, K. P. (2008). A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice. Hum. Mol. Genet. 17, 1201-1213.
29. Lapidos, K. A., Kakkar, R. and McNally, E. M. (2004). The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ. Res. 94, 1023-1031.
30. Le Grand, F. and Rudnicki, M. (2007). Satellite and stem cells in muscle growth and repair. Development 134, 3953-3957.
31. Lefaucheur, J. P., Pastoret, C. and Sebille, A. (1995). Phenotype of dystrophinopathy in old mdx mice. Anat. Rec. 242, 70-76.
32. Liu, L. A. and Engvall, E. (1999). Sarcoglycan isoforms in skeletal muscle. J. Biol. Chem. 274, 38171-38176.
33. Marics, I., Padilla, F., Guillemot, J. F., Scaal, M. and Marcelle, C. (2002). FGFR4 signaling is a necessary step in limb muscle differentiation. Development 129, 4559-4569.
34. Mauro, A. (1961). Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9, 493-495.
35. McArdle, A., Edwards, R. H. and Jackson, M. J. (1995). How does dystrophin deficiency lead to muscle degeneration?-evidence from the mdx mouse. Neuromuscul. Disord. 5, 445-456.
36. McNally, E. M., Yoshida, M., Mizuno, Y., Ozawa, E. and Kunkel, L. M. (1994). Human adhalin is alternatively spliced and the gene is located on chromosome 17q21. Proc. Natl. Acad. Sci. USA 91, 9690-9694.
37. Montanaro, F., Liadaki, K., Volinski, J., Flint, A. and Kunkel, L. M. (2003). Skeletal muscle engraftment potential of adult mouse skin side population cells. Proc. Natl. Acad. Sci. USA 100, 9336-9341.
38. Myers, J. M., Martins, G. G., Ostrowski, J. and Stachowiak, M. K. (2003). Nuclear trafficking of FGFR1: a role for the transmembrane domain. J. Cell. Biochem. 88, 1273-1291.
39. Olwin, B. B., Arthur, K., Hannon, K., Hein, P., McFall, A., Riley, B., Szebenyi, G., Zhou, Z., Zuber, M. E., Rapraeger, A. C. et al. (1994). Role of FGFs in skeletal muscle and limb development. Mol. Reprod. Dev. 39, 90-101.
40. Peng, H., Myers, J., Fang, X., Stachowiak, E. K., Maher, P. A., Martins, G. G., Popescu, G., Berezney, R. and Stachowiak, M. K. (2002). Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C. J. Neurochem. 81, 506-524.
41. Sacco, A., Mourkioti, F., Tran, R., Choi, J., Llewellyn, M., Kraft, P., Shkreli, M., Delp, S., Pomerantz, J. H., Artandi, S. E. et al. (2010). Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 143, 1059-1071.
42. Sampaolesi, M., Torrente, Y., Innocenzi, A., Tonlorenzi, R., D'Antona, G., Pellegrino, M. A., Barresi, R., Bresolin, N., De Angelis, M. G., Campbell, K. P. et al. (2003). Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301, 487-492.
43. Sheehan, S. M. and Allen, R. E. (1999). Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor. J. Cell. Physiol. 181, 499-506.
44. Shinin, V., Gayraud-Morel, B., Gomes, D. and Tajbakhsh, S. (2006). Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells. Nat. Cell Biol. 8, 677-687.
45. Smith, J. and Schofield, P. N. (1994). The effects of fibroblast growth factors in long-term primary culture of dystrophic (mdx) mouse muscle myoblasts. Exp. Cell Res. 210, 86-93.
46. Steinfeld, R., van den Berghe, H. and David, G. (1996). Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surfaceassociated syndecans and glypican. J. Cell Biol. 133, 405-416.
47. Tedesco, F. S., Hoshiya, H., D'Antona, G., Gerli, M. F., Messina, G., Antonini, S., Tonlorenzi, R., Benedetti, S., Berghella, L., Torrente, Y. et al. (2011). Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy. Sci. Transl. Med. 3, 96ra78.
48. Torrente, Y., Belicchi, M., Sampaolesi, M., Pisati, F., Meregalli, M., D'Antona, G., Tonlorenzi, R., Porretti, L., Gavina, M., Mamchaoui, K. et al. (2004). Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J. Clin. Invest. 114, 182-195.
49. Vainzof, M., Passos-Bueno, M. R., Canovas, M., Moreira, E. S., Pavanello, R. C., Marie, S. K., Anderson, L. V., Bonnemann, C. G., McNally, E. M., Nigro, V. et al. (1996). The sarcoglycan complex in the six autosomal recessive limbgirdle muscular dystrophies. Hum. Mol. Genet. 5, 1963-1969.
50. Vainzof, M., Moreira, E. S., Canovas, M., Anderson, L. V., Pavanello, R. C., Passos-Bueno, M. R. and Zatz, M. (2000). Partial alpha-sarcoglycan deficiency with retention of the dystrophin-glycoprotein complex in a LGMD2D family. Muscle Nerve 23, 984-988.
51. Weinstein, M., Xu, X., Ohyama, K. and Deng, C. X. (1998). FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 125, 3615-3623.
52. Weiss, L., Lubin, I., Factorowich, I., Lapidot, Z., Reich, S., Reisner, Y. and Slavin, S. (1994). Effective graft-versus-leukemia effects independent of graftversus- host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2. J. Immunol. 153, 2562-2567.
53. Yoshida, T., Pan, Y., Hanada, H., Iwata, Y. and Shigekawa, M. (1998). Bidirectional signaling between sarcoglycans and the integrin adhesion system in cultured L6 myocytes. J. Biol. Chem. 273, 1583-1590.
54. Zammit, P. S., Golding, J. P., Nagata, Y., Hudon, V., Partridge, T. A. and Beauchamp, J. R. (2004). Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? J. Cell Biol. 166, 347-357.
55. Zammit, P. S., Partridge, T. A. and Yablonka-Reuveni, Z. (2006). The skeletal muscle satellite cell: the stem cell that came in from the cold. J. Histochem. Cytochem. 54, 1177-1191.